111 related articles for article (PubMed ID: 15389206)
1. Treatment of infantile hemangiomas with short-term application of imiquimod 5% cream.
Welsh O; Olazarán Z; Gómez M; Salas J; Berman B
J Am Acad Dermatol; 2004 Oct; 51(4):639-42. PubMed ID: 15389206
[TBL] [Abstract][Full Text] [Related]
2. Topical imiquimod in the treatment of infantile hemangiomas: a retrospective study.
Ho NT; Lansang P; Pope E
J Am Acad Dermatol; 2007 Jan; 56(1):63-8. PubMed ID: 17190622
[TBL] [Abstract][Full Text] [Related]
3. Treating protruding infantile hemangiomas with topical imiquimod 5% cream caused severe local reactions and disfiguring scars.
Qiu Y; Ma G; Lin X; Jin Y; Chen H; Hu X
Pediatr Dermatol; 2013; 30(3):342-7. PubMed ID: 23046440
[TBL] [Abstract][Full Text] [Related]
4. A prospective self-controlled phase II study of imiquimod 5% cream in the treatment of infantile hemangioma.
Jiang C; Hu X; Ma G; Chen D; Jin Y; Chen H; Chen X; Lin X
Pediatr Dermatol; 2011; 28(3):259-66. PubMed ID: 21615472
[TBL] [Abstract][Full Text] [Related]
5. Proliferating hemangioma of infancy: successful treatment with topical 5% imiquimod cream.
Hazen PG; Carney JF; Engstrom CW; Turgeon KL; Reep MD; Tanphaichitr A
Pediatr Dermatol; 2005; 22(3):254-6. PubMed ID: 15916578
[TBL] [Abstract][Full Text] [Related]
6. [Clinical application of imiquimod for the treatment of infantile hemangiomas].
Ma G; Lin XX; Jiang CH; Chen H; Li W; Hu XJ; Jin YB; Chen D; Chen XD; Ye XX
Zhonghua Zheng Xing Wai Ke Za Zhi; 2011 Nov; 27(6):411-4. PubMed ID: 22292400
[TBL] [Abstract][Full Text] [Related]
7. Imiquimod 5% cream versus timolol 0.5% ophthalmic solution for treating superficial proliferating infantile haemangiomas: a retrospective study.
Qiu Y; Ma G; Yang J; Hu X; Chen H; Jin Y; Lin X
Clin Exp Dermatol; 2013 Dec; 38(8):845-50. PubMed ID: 23627540
[TBL] [Abstract][Full Text] [Related]
8. A phase II, open-label study of the efficacy and safety of imiquimod in the treatment of superficial and mixed infantile hemangioma.
McCuaig CC; Dubois J; Powell J; Belleville C; David M; Rousseau E; Gendron R; Jafarian F; Auger I
Pediatr Dermatol; 2009; 26(2):203-12. PubMed ID: 19419474
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of cutaneous hemangioma of infancy with topical imiquimod 5%: a report of 3 cases.
Senchak AJ; Dann M; Cable B; Bessinger G
Ear Nose Throat J; 2010 Mar; 89(3):E21-5. PubMed ID: 20229466
[TBL] [Abstract][Full Text] [Related]
10. Ulcerated infantile hemangioma treated with imiquimod.
Mascarenhas R; Guiote V; Agro J; Henrique M
Dermatol Online J; 2011 Sep; 17(9):13. PubMed ID: 21971278
[TBL] [Abstract][Full Text] [Related]
11. Involution of infantile haemangiomas after imiquimod 5% cream.
Barry RB; Hughes BR; Cook LJ
Clin Exp Dermatol; 2008 Jul; 33(4):446-9. PubMed ID: 18485022
[TBL] [Abstract][Full Text] [Related]
12. Topical imiquimod treatment of cutaneous vascular disorders in pediatric patients: clinical evaluation on the efficacy and safety.
Mao XH; Wang JY; Yan JL
J Zhejiang Univ Sci B; 2012 Sep; 13(9):745-50. PubMed ID: 22949365
[TBL] [Abstract][Full Text] [Related]
13. Infantile hemangioma: clinical resolution with 5% imiquimod cream.
Martinez MI; Sanchez-Carpintero I; North PE; Mihm MC
Arch Dermatol; 2002 Jul; 138(7):881-4; discussion 884. PubMed ID: 12071813
[No Abstract] [Full Text] [Related]
14. Use of 5% imiquimod cream in the treatment of facial basal cell carcinoma: a 3-year retrospective follow-up study.
Vun Y; Siller G
Australas J Dermatol; 2006 Aug; 47(3):169-71. PubMed ID: 16866996
[TBL] [Abstract][Full Text] [Related]
15. A pilot study of treatment of lentigo maligna with 5% imiquimod cream.
Fleming CJ; Bryden AM; Evans A; Dawe RS; Ibbotson SH
Br J Dermatol; 2004 Aug; 151(2):485-8. PubMed ID: 15327559
[TBL] [Abstract][Full Text] [Related]
16. Topical imiquimod treatment of superficial and nodular basal cell carcinomas in patients affected by basal cell nevus syndrome: a preliminary report.
Micali G; De Pasquale R; Caltabiano R; Impallomeni R; Lacarrubba F
J Dermatolog Treat; 2002 Sep; 13(3):123-7. PubMed ID: 12227875
[TBL] [Abstract][Full Text] [Related]
17. Open-label nonrandomized left-right comparison of imiquimod 5% ointment and timolol maleate 0.5% eye drops in the treatment of proliferating superficial infantile hemangioma.
Hu L; Huang HZ; Li X; Lin XX; Li W
Dermatology; 2015; 230(2):150-5. PubMed ID: 25633200
[TBL] [Abstract][Full Text] [Related]
18. Management of infantile hemangiomas : current and potential pharmacotherapeutic approaches.
Craiglow BG; Antaya RJ
Paediatr Drugs; 2013 Apr; 15(2):133-8. PubMed ID: 23456550
[TBL] [Abstract][Full Text] [Related]
19. Primary cutaneous CD30+ T-cell lymphoma responsive to topical imiquimod (Aldara).
Didona B; Benucci R; Amerio P; Canzona F; Rienzo O; Cavalieri R
Br J Dermatol; 2004 Jun; 150(6):1198-201. PubMed ID: 15214911
[TBL] [Abstract][Full Text] [Related]
20. Treatment of Bowen's disease with topical 5% imiquimod cream: retrospective study.
Rosen T; Harting M; Gibson M
Dermatol Surg; 2007 Apr; 33(4):427-31; discussion 431-2. PubMed ID: 17430376
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]